Asset Details
Do you wish to reserve the book?
Phenotype standardization for drug-induced kidney disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Phenotype standardization for drug-induced kidney disease
Do you wish to request the book?
Phenotype standardization for drug-induced kidney disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Phenotype standardization for drug-induced kidney disease
2015
Overview
Drug-induced kidney disease is a frequent cause of renal dysfunction; however, there are no standards to identify and characterize the spectrum of these disorders. We convened a panel of international, adult and pediatric, nephrologists and pharmacists to develop standardized phenotypes for drug-induced kidney disease as part of the phenotype standardization project initiated by the International Serious Adverse Events Consortium. We propose four phenotypes of drug-induced kidney disease based on clinical presentation: acute kidney injury, glomerular, tubular, and nephrolithiasis, along with the primary and secondary clinical criteria to support the phenotype definition, and a time course based on the KDIGO/AKIN definitions of acute kidney injury, acute kidney disease, and chronic kidney disease. Establishing causality in drug-induced kidney disease is challenging and requires knowledge of the biological plausibility for the specific drug, mechanism of injury, time course, and assessment of competing risk factors. These phenotypes provide a consistent framework for clinicians, investigators, industry, and regulatory agencies to evaluate drug nephrotoxicity across various settings. We believe that this is the first step to recognizing drug-induced kidney disease and developing strategies to prevent and manage this condition.
Publisher
Elsevier Inc,Elsevier Limited
Subject
/ Acute Kidney Injury - chemically induced
/ Acute Kidney Injury - pathology
/ Biopsy
/ drugs
/ Glycosuria - chemically induced
/ Hematuria - chemically induced
/ Humans
/ Kidney Glomerulus - drug effects
/ Kidney Glomerulus - pathology
/ Kidney Glomerulus - physiopathology
/ Kidney Tubules - drug effects
/ Kidney Tubules - physiopathology
/ Necrosis - chemically induced
/ Nephritis, Interstitial - chemically induced
/ Nephrolithiasis - chemically induced
We currently cannot retrieve any items related to this title. Kindly check back at a later time.